Back
Novo Integrated Sciences 10K Form
Sell
40
NVOS
Novo Integrated Sciences
Last Price:
0.60
Seasonality Move:
1.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NVOS News And Ratings
See the #1 stock for the next 7 days that we like better than NVOS
NVOS Financial Statistics
Sales & Book Value
| Annual Sales: | $12.57M |
|---|---|
| Cash Flow: | $-1.71M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.25 |
| Price / Book: | 0.52 |
Profitability
| EPS (TTM): | -0.64000 |
|---|---|
| Net Income (TTM): | $-12.08M |
| Gross Margin: | $4.95M |
| Return on Equity: | -49.15% |
| Return on Assets: | -33.57% |
Novo Integrated Sciences Earnings Forecast
Key Novo Integrated Sciences Financial Ratios
- The Gross Profit Margin over the past 17 years for NVOS is 39.39%.
- The Selling, General & Administrative Expenses for NVOS have been equal to 107.43% of Gross Profit Margin.
- The Interest Expense is -38.73% of Operating Income.
- The Net Earning history of NVOS is -105.11% of Total Revenues.
- Per Share Earnings over the last 20 years have been positive in 11 years.
Novo Integrated Sciences Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Providers & Services |
| Sector: | Health Care |
| Current Symbol: | NVOS |
| Website: | novointegrated.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 0.5 |
| Quick Ratio: | 0.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NVOS Technical Analysis vs Fundamental Analysis
Sell
40
Novo Integrated Sciences (NVOS)
is a Sell
Is Novo Integrated Sciences a Buy or a Sell?
-
Novo Integrated Sciences stock is rated a Sell
The current Novo Integrated Sciences [NVOS] share price is $0.60. The Score for NVOS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.